434P CodeBreaK 101 subprotocol H: Phase Ib study evaluating combination of sotorasib (Soto), a KRASG12C inhibitor, and panitumumab (PMab), an EGFR inhibitor, in advanced KRAS p.G12C-mutated colorectal cancer (CRC)

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Strickler, John

Cited Authors

Fakih, M; Falchook, GS; Hong, DS; Yaeger, RD; Chan, E; Mather, O; Cardona, P; Dai, T; Strickler, J

Published Date

September 2021

Published In

Annals of Oncology

Volume / Issue

32 /

Start / End Page

S551 - S551

Published By

Elsevier BV

International Standard Serial Number (ISSN)

0923-7534

Digital Object Identifier (DOI)

10.1016/j.annonc.2021.08.955